• General Drug Summary
    • Drug Name
    • Busulfan
    • Description
    • An alkylating agent having a selective immunosuppressive effect on bone marrow. It has been used in the palliative treatment of chronic myeloid leukemia (myeloid leukemia, chronic), but although symptomatic relief is provided, no permanent remission is brought about. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), busulfan is listed as a known carcinogen. [PubChem]
    • Also Known As
    • Busulphan; Busulphane; Butanedioldimethanesulfonate; Buzulfan; Sulfabutin; Sulphabutin; Tetramethylene Dimethane Sulfonate; Tetramethylenester Kyseliny Methansulfonove
    • Categories
    • Myeloablative Agonis
    • Groups
    • approved
    • Structure
  • Summary In Neonatal Jaundice
    • 1 record(s) for Busulfan Effective in Maintaining Remission in Neonatal Jaundice.
    • PMID
    • Drug Name
    • Efficacy
    • Evidence
    • 11041572
    • Busulfan
    • Effective in Maintaining Remission
    • Clinical Trial

Copyright @ 2016, Genetics and Bioinformatics Lab. All Rights Reserved.